These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

246 related items for PubMed ID: 30129421

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Cytochrome P450 2C9 *2 and *3 polymorphisms and the dose and effect of sulfonylurea in type II diabetes mellitus.
    Becker ML, Visser LE, Trienekens PH, Hofman A, van Schaik RH, Stricker BH.
    Clin Pharmacol Ther; 2008 Feb; 83(2):288-92. PubMed ID: 17597710
    [Abstract] [Full Text] [Related]

  • 3. Association between the CYP2C9 polymorphism and the drug metabolism phenotype.
    Topić E, Stefanović M, Samardzija M.
    Clin Chem Lab Med; 2004 Jan; 42(1):72-8. PubMed ID: 15061384
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Distribution of CYP2C8 and CYP2C9 amino acid substitution alleles in South Indian diabetes patients: A genotypic and computational protein phenotype study.
    Rao DK, Murthy DK, Shaik NS, Banaganapalli B, Konda K, Rao HP, Ganti E, Ahmed Awan Z, A El-Harouni A, Elango R, Ali Khan I, Shaik NA.
    Clin Exp Pharmacol Physiol; 2017 Dec; 44(12):1171-1179. PubMed ID: 28686288
    [Abstract] [Full Text] [Related]

  • 6. The Effect of CYP2C9 Genotype Variants in Type 2 Diabetes on the Pharmacological Effectiveness of Sulfonylureas, Diabetic Retinopathy, and Nephropathy.
    Saberi M, Ramazani Z, Rashidi H, Saberi A.
    Vasc Health Risk Manag; 2020 Dec; 16():241-248. PubMed ID: 32606720
    [Abstract] [Full Text] [Related]

  • 7. Effect of genetic polymorphisms in cytochrome p450 (CYP) 2C9 and CYP2C8 on the pharmacokinetics of oral antidiabetic drugs: clinical relevance.
    Kirchheiner J, Roots I, Goldammer M, Rosenkranz B, Brockmöller J.
    Clin Pharmacokinet; 2005 Dec; 44(12):1209-25. PubMed ID: 16372821
    [Abstract] [Full Text] [Related]

  • 8. Allele and genotype frequencies of CYP2C9 within an Iranian population (Mazandaran).
    Hashemi-Soteh SM, Shahabi-Majd N, Gholizadeh AR, Shiran MR.
    Genet Test Mol Biomarkers; 2012 Jul; 16(7):817-21. PubMed ID: 22288731
    [Abstract] [Full Text] [Related]

  • 9. Genetic polymorphisms of cytochrome P450 enzymes 2C9 and 2C19 in a healthy Iranian population.
    Zand N, Tajik N, Moghaddam AS, Milanian I.
    Clin Exp Pharmacol Physiol; 2007 Jul; 34(1-2):102-5. PubMed ID: 17201743
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Cytochrome P450 2C9 gene polymorphism and warfarin maintenance dosage in pediatric patients: A systematic review and meta-analysis.
    Zhang J, Tian L, Huang J, Huang S, Chai T, Shen J.
    Cardiovasc Ther; 2017 Feb; 35(1):26-32. PubMed ID: 27661060
    [Abstract] [Full Text] [Related]

  • 12. Cytochrome P450 2C19 enzyme, Cytochrome P450 2C9 enzyme, and Cytochrome P450 2D6 enzyme allelic variants and its possible effect on drug metabolism: A retrospective study.
    Naujokaitis D, Asmoniene V, Kadusevicius E.
    Medicine (Baltimore); 2021 Mar 19; 100(11):e24545. PubMed ID: 33725937
    [Abstract] [Full Text] [Related]

  • 13. High allele frequency of CYP2C9*3 (rs1057910) in a Negrito's subtribe population in Malaysia; Aboriginal people of Jahai.
    Rosdi RA, Mohd Yusoff N, Ismail R, Soo Choon T, Saleem M, Musa N, Yusoff S.
    Ann Hum Biol; 2016 Sep 19; 43(5):445-50. PubMed ID: 26402341
    [Abstract] [Full Text] [Related]

  • 14. Genetic Polymorphism of CYP2C9 Among Sistani Ethnic Group in Gorgan.
    Marjani A, Gharanjik AM.
    Indian J Clin Biochem; 2018 Apr 19; 33(2):208-213. PubMed ID: 29651213
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Hypoglycemia and Glycemic Control With Glyburide in Women With Gestational Diabetes and Genetic Variants of Cytochrome P450 2C9 and/or OATP1B3.
    Bouchghoul H, Bouyer J, Senat MV, Mandelbrot L, Letourneau A, Bourcigaux N, Becquemont L, Verstuyft C.
    Clin Pharmacol Ther; 2021 Jul 19; 110(1):141-148. PubMed ID: 33341937
    [Abstract] [Full Text] [Related]

  • 17. Clinical relevance of genetic polymorphism in CYP2C9 gene to pharmacodynamics and pharmacokinetics of phenytoin in epileptic patients: validatory pharmacogenomic approach to pharmacovigilance.
    Kousar S, Wafai ZA, Wani MA, Jan TR, Andrabi KI.
    Int J Clin Pharmacol Ther; 2015 Jul 19; 53(7):504-16. PubMed ID: 25943175
    [Abstract] [Full Text] [Related]

  • 18. Effects of cytochrome P450 2C9 polymorphism on bosentan metabolism.
    Chen M, Zhang Y, Pan P, Wang L, Zhan Y, Jin H, Xia M, Wang X, Dai D, Cai J, Hu G.
    Drug Metab Dispos; 2014 Nov 19; 42(11):1820-5. PubMed ID: 25142737
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Genetic polymorphisms analysis of drug-metabolizing enzyme CYP2C9 in the Uyghur population.
    Jin T, Xun X, Du S, Geng T, Wang H, Feng T, Chen C, Yuan D, Kang L.
    Xenobiotica; 2016 Aug 19; 46(8):709-14. PubMed ID: 26610168
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.